On-demand pre-exposure prophylaxis with tenofovir disoproxil fumarate plus emtricitabine among men who have sex with men with less frequent sexual intercourse: a post-hoc analysis of the ANRS IPERGAY trial
- 1 February 2020
- journal article
- research article
- Published by Elsevier BV in The Lancet HIV
- Vol. 7 (2), e113-e120
- https://doi.org/10.1016/s2352-3018(19)30341-8
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 InfectionThe New England Journal of Medicine, 2015
- Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trialThe Lancet, 2015
- Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort studyThe Lancet Infectious Diseases, 2014
- Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis Efficacy in Men Who Have Sex with MenScience Translational Medicine, 2012
- Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with MenThe New England Journal of Medicine, 2010
- Intermittent Prophylaxis with Oral Truvada Protects Macaques from Rectal SHIV InfectionScience Translational Medicine, 2010
- Recommended tests for association in 2×2 tablesStatistics in Medicine, 2009
- Prevention of Rectal SHIV Transmission in Macaques by Daily or Intermittent Prophylaxis with Emtricitabine and TenofovirPLoS Medicine, 2008
- Dynamics of HIV viremia and antibody seroconversion in plasma donorsAIDS, 2003
- Mid-P Confidence Intervals: A Brief ReviewJournal of the Royal Statistical Society: Series D (The Statistician), 1995